Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle

Diabetologia

Volumn 52, Issue 4, 2009, Pages 664-674

  Eckardt, K ^a   Sell, H ^a   Taube, A ^a   Koenen, M ^a   Platzbecker, B ^a   Cramer, A ^a   Horrighs, A ^a   Lehtonen, M ^b   Tennagels, N ^c   Eckel, J ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Adipocyte conditioned medium; Anandamide; Cannabinoid receptor type 1; Endocannabinoids; Human skeletal muscle cells; Insulin resistance; Rimonabant

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; FAT; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B;

ADIPOCYTE; ADULT; ARTICLE; CELL DIFFERENTIATION; CHILD; ENZYME ACTIVATION; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; INSULIN RESISTANCE; MALE; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; SCHOOL CHILD; SKELETAL MUSCLE; WESTERN BLOTTING;

ADIPOCYTES; ADIPOSE TISSUE; ARACHIDONIC ACIDS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; ENDOCANNABINOIDS; HUMANS; INSULIN RESISTANCE; MUSCLE, SKELETAL; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTOR CROSS-TALK; RECEPTOR, CANNABINOID, CB1;

EID: 61449252830     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-008-1240-4     Document Type: Article

References (47)

1. I Matias V Di Marzo 2007 Endocannabinoids and the control of energy balance Trends Endocrinol Metab 18 27 37
2. D Cota G Marsicano M Tschop 2003 The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis J Clin Invest 112 423 431
3. V Di Marzo I Matias 2005 Endocannabinoid control of food intake and energy balance Nat Neurosci 8 585 589
4. R Maldonado O Valverde F Berrendero 2006 Involvement of the endocannabinoid system in drug addiction Trends Neurosci 29 225 232
5. RG Pertwee 2001 Cannabinoid receptors and pain Prog Neurobiol 63 569 611
6. R de Fonseca AI Del FJ Bermudez-Silva A Bilbao A Cippitelli M Navarro 2005 The endocannabinoid system: physiology and pharmacology Alcohol Alcohol 40 2 14
7. M Beltramo N Stella A Calignano SY Lin A Makriyannis D Piomelli 1997 Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 277 1094 1097
8. BF Cravatt DK Giang SP Mayfield DL Boger RA Lerner NB Gilula 1996 Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 83 87
9. TP Dinh D Carpenter FM Leslie 2002 Brain monoglyceride lipase participating in endocannabinoid inactivation Proc Natl Acad Sci U S A 99 10819 10824
10. I Matias MP Gonthier P Orlando 2006 Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia J Clin Endocrinol Metab 91 3171 3180
11. D Osei-Hyiaman M DePetrillo P Pacher 2005 Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity J Clin Invest 115 1298 1305
12. V Di Marzo SK Goparaju L Wang 2001 Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 822 825
13. S Engeli J Bohnke M Feldpausch 2005 Activation of the peripheral endocannabinoid system in human obesity Diabetes 54 2838 2843
14. M Bluher S Engeli N Kloting 2006 Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity Diabetes 55 3053 3060
15. C Ravinet-Trillou C Delgorge C Menet M Arnone P Soubrie 2004 CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity Int J Obes Relat Metab Disord 28 640 648
16. A Dresner D Laurent M Marcucci 1999 Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity J Clin Invest 103 253 259
17. ME Griffin MJ Marcucci GW Cline 1999 Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade Diabetes 48 1270 1274
18. P Trayhurn IS Wood 2005 Signalling role of adipose tissue: adipokines and inflammation in obesity Biochem Soc Trans 33 1078 1081
19. H Sell J Eckel D Dietze-Schroeder 2006 Pathways leading to muscle insulin resistance: the muscle-fat connection Arch Physiol Biochem 112 105 113
20. D Dietze M Koenen K Rohrig H Horikoshi H Hauner J Eckel 2002 Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes Diabetes 51 2369 2376
21. D Dietze S Ramrath O Ritzeler N Tennagels H Hauner J Eckel 2004 Inhibitor kappaB kinase is involved in the paracrine crosstalk between human fat and muscle cells Int J Obes Relat Metab Disord 28 985 992
22. MP Gonthier L Hoareau F Festy 2007 Identification of endocannabinoids and related compounds in human fat cells Obesity (Silver Spring) 15 837 845
23. C Pagano C Pilon A Calcagno 2007 The endogenous cannabinoid system stimulates glucose uptake in human fat cells via PI3-kinase and calcium-dependent mechanisms J Clin Endocrinol Metab 92 4810 4819
24. V Gasperi F Fezza N Pasquariello 2007 Endocannabinoids in adipocytes during differentiation and their role in glucose uptake Cell Mol Life Sci 64 219 229
25. P Cavuoto AJ McAinch G Hatzinikolas D Cameron-Smith GA Wittert 2007 Effects of cannabinoid receptors on skeletal muscle oxidative pathways Mol Cell Endocrinol 267 63 69
26. YL Liu IP Connoley CA Wilson MJ Stock 2005 Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice Int J Obes (Lond) 29 183 187
27. H Sell D Dietze-Schroeder U Kaiser J Eckel 2006 Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle Endocrinology 147 2458 2467
28. RG Pertwee 2005 Inverse agonism and neutral antagonism at cannabinoid CB1 receptors Life Sci 76 1307 1324
29. SJ Gatley AN Gifford ND Volkow R Lan A Makriyannis 1996 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors Eur J Pharmacol 307 331 338
30. J Lo Verme J Fu G Astarita 2005 The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide Mol Pharmacol 67 15 19
31. S Engeli K Heusser J Janke 2008 Peripheral endocannabinoid system activity in patients treated with sibutramine Obesity (Silver Spring) 16 1135 1137
32. M Bensaid M Gary-Bobo A Esclangon 2003 The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells Mol Pharmacol 63 908 914
33. DJ Dyck GJ Heigenhauser CR Bruce 2006 The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity Acta Physiol (Oxf) 186 5 16
34. S Migrenne A Lacombe AL Lefevre 2008 Adiponectin is required to mediate rimonabant-induced improvements of insulin sensitivity but not body weight loss in diet-induced obese mice Diabetes 57 Suppl 1 A31 Abstract
35. M Gary-Bobo G Elachouri JF Gallas 2007 Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats Hepatology 46 122 129
36. A Schafer J Pfrang J Neumuller S Fiedler G Ertl J Bauersachs 2008 The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats Br J Pharmacol 154 1047 1054
37. Z Gao D Hwang F Bataille 2002 Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex J Biol Chem 277 48115 48121
38. V Aguirre ED Werner J Giraud YH Lee SE Shoelson MF White 2002 Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action J Biol Chem 277 1531 1537
39. RC Hresko M Mueckler 2005 mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes J Biol Chem 280 40406 40416
40. DD Sarbassov DA Guertin SM Ali DM Sabatini 2005 Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex Science 307 1098 1101
41. DR Alessi SR James CP Downes 1997 Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha Curr Biol 7 261 269
42. DR Alessi M Andjelkovic B Caudwell 1996 Mechanism of activation of protein kinase B by insulin and IGF-1 EMBO J 15 6541 6551
43. E Jacinto V Facchinetti D Liu 2006 SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity Cell 127 125 137
44. DA Guertin DM Stevens CC Thoreen 2006 Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKcalpha, but not S6K1 Dev Cell 11 859 871
45. C De Alvaro T Teruel R Hernandez M Lorenzo 2004 Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner J Biol Chem 279 17070 17078
46. G Li EJ Barrett MO Barrett W Cao Z Liu 2007 Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway Endocrinology 148 3356 3363
47. HA Koistinen AV Chibalin JR Zierath 2003 Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients Diabetologia 46 1324 1328